Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation

被引:64
作者
Zerbini, Alessandro [1 ]
Pilli, Massimo [1 ]
Fagnoni, Francesco [2 ]
Pelosi, Guido [1 ]
Pizzi, Maria Grazia [1 ]
Schivazappa, Simona [1 ]
Laccabue, Diletta [1 ]
Cavallo, Cristina [1 ]
Schianchi, Claudia [1 ]
Ferrari, Carlo [1 ]
Missale, Gabriele [1 ]
机构
[1] Univ Parma, Div Malattie Infett & Epatol, Azienda Osped, Unit Infect Dis & Hepatol, I-43100 Parma, Italy
[2] IRCCS, Expt Oncol Lab, Fdn Salvatore Maugeri Clin, Pavia, Italy
关键词
HCC; DC; RFA;
D O I
10.1097/CJI.0b013e318160ff1c
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiofrequency thermal ablation represents an effective treatment for hepatocellular carcinoma (HCC) and it can also exert an "adjuvant" effect on spontaneous antitumor T-cell responses, as suggested by human and animal studies. The adjuvant effect is thought to depend on the huge amount of necrotic tumor antigen made available to the immune system by HCC thermal ablation. In addition, radiofrequency thermal ablation may result in the release of local stimuli responsible for activation and maturation of antigen-presenting cells (APCs). To test this hypothesis, we studied APC maturation and function in 19 patients undergoing thermal ablation for HCC. Patients' monocytes induced to differentiate with granulocyte macrophage colony-stimulating factor (GM-CSF), or GM-CSF plus IL-4, were cocultured in vitro with tumor debris generated by radiofrequency thermal ablation. Expression of costimulatory molecules, lymphnode homing chemokine receptor, antigen presentation, and cytokine secretion were enhanced by incubation with HCC treated tissue as compared with untreated HCC and nontumor liver tissue. Moreover, HCC-specific T-cell responses could be induced by monocytes activated with GMCSF and incubated with thermally ablated HCC tissue. HCC thermal ablation can create an antigenic source along with stimuli appropriate for maturation of APCs to induce HCC-specific T-cell responses. These results contribute to explain at least in part the adjuvant effect of HCC thermal ablation and suggest a novel strategy to induce maturation of APCs and their loading with HCC antigens for active immunotherapy protocols aimed at reducing HCC recurrence after thermal ablation.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 35 条
[1]   Activation of dendritic cells by local ablation of hepatocellular carcinoma [J].
Ali, MY ;
Grimm, CF ;
Ritter, M ;
Mohr, L ;
Allgaier, HP ;
Weth, R ;
Bocher, WO ;
Endrulat, K ;
Blum, HE ;
Geissler, M .
JOURNAL OF HEPATOLOGY, 2005, 43 (05) :817-822
[2]   New therapies for hepatocellular carcinoma [J].
Avila, M. A. ;
Berasain, C. ;
Sangro, B. ;
Prieto, J. .
ONCOGENE, 2006, 25 (27) :3866-3884
[3]   Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12 [J].
Barajas, M ;
Mazzolini, G ;
Genové, G ;
Bilbao, R ;
Narvaiza, I ;
Schmitz, V ;
Sangro, B ;
Melero, I ;
Qian, C ;
Prieto, J .
HEPATOLOGY, 2001, 33 (01) :52-61
[4]  
Chang AE, 2002, CLIN CANCER RES, V8, P1021
[5]   Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors [J].
Dauer, M ;
Obermaier, B ;
Herten, J ;
Haerle, C ;
Pohl, K ;
Rothenfusser, S ;
Schnurr, M ;
Endres, S ;
Eigler, A .
JOURNAL OF IMMUNOLOGY, 2003, 170 (08) :4069-4076
[6]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350
[7]   Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity [J].
den Brok, M. H. M. G. M. ;
Sutmuller, R. P. M. ;
Nierkens, S. ;
Bennink, E. J. ;
Frielink, C. ;
Toonen, L. W. J. ;
Boerman, O. C. ;
Figdor, C. G. ;
Ruers, T. J. M. ;
Adema, G. J. .
BRITISH JOURNAL OF CANCER, 2006, 95 (07) :896-905
[8]   In situ tumor ablation creates an antigen source for the generation of antitumor immunity [J].
den Brok, MHMGM ;
Sutmuller, RPM ;
van der Voort, R ;
Bennink, EJ ;
Figdor, CG ;
Ruers, TJM ;
Adema, GJ .
CANCER RESEARCH, 2004, 64 (11) :4024-4029
[9]  
Di Pucchio T, 2003, EUR J IMMUNOL, V33, P358
[10]   Dendritic cell immunotherapy: mapping the way [J].
Figdor, CG ;
de Vries, IJM ;
Lesterhuis, WJ ;
Melief, CJM .
NATURE MEDICINE, 2004, 10 (05) :475-480